Effect of calcitonin gene-related peptide (-receptor) antibodies in chronic cluster headache: Results from a retrospective case series support individual treatment attempts
Author(s) -
Ruth Ruscheweyh,
Gregor Broessner,
Gudrun Goßrau,
Katja HeinzeKuhn,
Tim Jürgens,
Katharina Kaltseis,
Katharina Kamm,
Andreas Peikert,
Bianca Raffaelli,
Florian Rimmele,
Stefan Evers
Publication year - 2020
Publication title -
cephalalgia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.57
H-Index - 125
eISSN - 1468-2982
pISSN - 0333-1024
DOI - 10.1177/0333102420949866
Subject(s) - calcitonin gene related peptide , medicine , cluster headache , calcitonin , antibody , receptor , monoclonal antibody , gastroenterology , migraine , immunology , neuropeptide
To assess the efficacy of monoclonal antibodies targeting calcitonin gene-related peptide (CGRP) or its receptor in chronic cluster headache (CCH) treatment under real world conditions.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom